The RISCC project coordinator, Hans Bekhoff, was interviewed on early July by EU Research, which is now available to view online:

" Personalised Screening Strategies: RISCC project Redefines Cervical Cancer Prevention ". You can read the article describing the project methodology and its background here

The complete reference: Berkhof, J. Robles, C. (2023) ‘Personalised Screening Strategies: RISCC project Redefines Cervical Cancer Prevention’, EU Research, Autumn 2023 vol. (35), pp. 18 -19.

A new publication of the RISCC consortium is published online ahead of print in The Lancet Regional Health - Europe. This study confirmed that HPV testing on self-collected samples is an accurate alternative to HPV testing on clinician-collected samples in primary HPV-based screening programmes. First author is Federica Inturrisi. The full manuscript can be found here (https://doi.org/10.1016/j.lanepe.2021.100235). A visual summary of the study can be found below.

A new publication of the RISCC consortium is published online ahead of print in Cancer Epidemiology, Biomarkers & Prevention. The study aims to demonstrate the potential of 5-year HPV type concordance as a disease marker for HPV-positive and cytology-negative women. First author is Federica Inturrisi. The full manuscript can be found here. A visual summary of the study can be found below.

A new publication of the RISCC consortium was published this summer in the International Journal of Cancer. This research study conducted by Federica Inturrisi and colleagues aims to estimate the lifetime risk of (screen-detected) CIN2+ and CIN3+, using the using the Population‐based Screening Study Amsterdam (POBASCAM). The full manuscript can be found here. A visual summary of the study can be found below.